Calycosin rebalances advanced glycation end products-induced glucose uptake dysfunction of hepatocyte in vitro

American Journal of Chinese Medicine

Volumn 43, Issue 6, 2015, Pages 1191-1210

  Xu, Youhua ^a   Xiong, Jianfeng ^a   Zhao, Yonghua ^a   He, Bao ^b   Zheng, Zhaoguang ^b   Chu, Gejin ^a   Zhu, Quan ^a,b  

^a MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Macao)

^b Institute of Consun Co for Chinese Medicine in Kidney Diseases   (China)

Author keywords

Advanced Glycation End Products; Calycosin; Glucose Uptake; Hepatocyte; Radix Astragali

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; BROXURIDINE; CALYCOSIN; CYCLIC AMP; ESTROGEN RECEPTOR; FULVESTRANT; GLUCOSE; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 4; 7,3'-DIHYDROXY-4'-METHOXYISOFLAVONE; ISOFLAVONE DERIVATIVE; PHYTOESTROGEN; PLANT EXTRACT;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DAMAGE; CELL MEMBRANE; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; ENZYME IMMUNOASSAY; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLYCATION; IMMUNOFLUORESCENCE; IN VITRO STUDY; INTRACELLULAR SIGNALING; LIVER CELL; LIVER CELL DAMAGE; MTT ASSAY; NONHUMAN; PROTEIN EXPRESSION; RAT; UPREGULATION; ANIMAL; ASTRAGALUS (PLANT); CELL LINE; CHEMISTRY; DRUG EFFECTS; METABOLISM; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; ASTRAGALUS PLANT; BIOLOGICAL TRANSPORT; CELL LINE; GLUCOSE; GLYCOSYLATION END PRODUCTS, ADVANCED; HEPATOCYTES; ISOFLAVONES; PHYTOESTROGENS; PLANT EXTRACTS; RATS;

EID: 84943530872     PISSN: 0192415X     EISSN: 17936853     Source Type: Journal    
DOI: 10.1142/S0192415X15500688     Document Type: Article

References (41)

1. Aschenbach, J.R., K. Steglich, G. Gäbel and K.U. Honscha. Expression of mRNA for glucose transport proteins in jejunum, liver, kidney and skeletal muscle of pigs. J. Physiol. Biochem. 65: 251-266, 2009.
2. Augustin, R. The protein family of glucose transport facilitators: It's not only about glucose after all. IUBMB Life 62: 315-333, 2010.
3. Bell, G.I., T. Kayano, J.B. Buse, C.F. Burant, J. Takeda, D. Lin, H. Fukumoto and S. Seino. Molecular biology of mammalian glucose transporters. Diabetes Care 13: 198-208, 1990.
4. Bhattacharya, S., R. Gachhui and P.C. Sil. The prophylactic role of D-saccharic acid-1,4-lactone against hyperglycemia-induced hepatic apoptosis via inhibition of both extrinsic and intrinsic pathways in diab etic rats. Food Funct. 4: 283-296, 2013.
5. Cai, W., M. Ramdas, L. Zhu, X. Chen, G.E. Striker and H. Vlassara. Oral advanced glycation end products (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1. Proc. Natl. Acad. Sci. USA 109: 15888-15893, 2012.
6. Cai, W., J. Uribarri, L. Zhu, X. Chen, S. Swamy, Z. Zhao, F. Grosjean, C. Simonaro, G.A. Kuchel, M. Schnaider-Beeri, M. Woodward, G.E. Striker and H. Vlassara. Oral glycotoxins are a modifiable cause of dementia and the metabolic syndrome in mice and humans. Proc. Natl. Acad. Sci. USA 111: 4940-4945, 2014.
7. Cederroth, C.R., M. Vinciguerra, A. Gjinovci, F. Kü hne, M. Klein, M. Cederroth, D. Caille, M. Suter, D. Neumann, R.W. James, D.R. Doerge, T. Wallimann, P. Meda, M. Foti, F. Rohner-Jeanrenaud, J.D. Vassalli and S. Nef. Dietary phytoestrogens activate AMP-Activated protein kinase with improvement in lipid and glucose metabolism. Diabetes 57: 1176-1185, 2008.
8. Chen, J., R. Hou, X. Zhang, Y. Ye, Y. Wang and J. Tian. Calycosin suppresses breast cancer cell growth via ER?-dependent regulation of IGF-1R, p38 MAPK and PI3K/Akt pathways. Plos One 9: e91245, 2014.
9. Cheong S.H.,K. Furuhashi,K. Ito,M. Nagaoka,T. Yonezawa,Y. Miura,K. Yagasaki Daidzein promotes glucose uptake through glucose transporter 4 translocation to plasma membrane in L6 myocytes and improves glucose homeostasis in Type 2 diabetic model mice. J. Nutr. Biochem. 25 136-143 2014.
10. Chin, E., A.M. Zamah, D. Landau, H. Gronbcek, A. Flyvbjerg, D. LeRoith and C.A. Bondy. Changes in facilitative glucose transporter messenger ribonucleic acid levels in the diabet ic rat kidney. Endocrinology 138: 1267-1275, 1997.
11. Deng, J.Y., P.S. Hsieh, J.P. Huang, L.S. Lu and L.M. Hung. Activation of estrogen receptor is crucial for resveratrol-stimulating muscular glucose uptake via both insulin-dependent and-independent pathways. Diabetes 57: 1814-1823, 2008.
12. Dominguez, J.H., K. Camp, L. Maianu, H. Feister and W.T. Garvey. Molecular adaptations of GLUT1 and GLUT2 in renal proximal tubules of diabetic rats. Am. J. Physiol. 266: F283-F290, 1994.
13. Edelstein, D. and M. Brownlee. Mechanistic studies of advanced glycosylation end product inhibition by aminoguanidine. Diabetes 41: 26-29, 1992.
14. Garrido, P., J. Morán, A. Alonso, S. González and C. González. 17?-estradiol activates glucose uptake via GLUT4 translocation and PI3K/Akt signaling pathway in MCF-7 cells. Endocrinology 154: 1979-1989, 2013.
15. Goldin, A., J.A. Beckman, A.M. Schmidt and M.A. Creager. Advanced glycation end products: Sparking the development of diabetic vascular injury. Circulation 114: 597-605, 2006.
16. Gorovits, N. and M.J. Charron. What we know about facilitative glucose transporters-Lessons from cultured cells, animal models, and human studies. Biochem. Mol. Biol. Educ. 31: 163-172, 2003.
17. Gorres, B.K., G.L. Bomhoff, J.K. Morris and P.C. Geiger. In vivo stimulation of oestrogen receptor-increases insulin-stimulated skeletal muscle glucose uptake. J. Physiol. 589: 2041-2054, 2011.
18. Gui, S .Y., W. Wei, H. Wang, L. Wu, W.Y. Sun, W.B. Chen and C.Y. Wu. Effects and mechanisms of crude astragalosides fraction on liver fibrosis in rats. J. Ethnopharmacol. 103: 154-159, 2006.
19. Hoffle r, U., K. Hobbie, R. Wilson, R. Bai, A. Rahman, D. Malarkey, G. Travlos and B.I. Ghanayem. Diet-induced obesity is associated with hyperleptinemia, hyperinsulinemia, hepatic steatosis, and glomerulopathy in C57Bl/6J mice. Endocrine 36: 311-325, 2009.
20. Holland-Fischer, P., J. Greisen, T. Grøfte, T.S. Jensen, P.O. Hansen and H. Vilstrup. Increased energy expenditure and glucose oxidation during acute nontraumatic skin pain in humans. E ur. J. Anaesthesiol. 26: 311-317, 2009.
21. Kanazawa, I., K. Tanaka and T. Sugimoto. DPP-4 inhibitors improve liver dysfunction in type 2 diabetes mellitus. Med. Sci. Monit. 20: 1662-1667, 2014.
22. Lal, M.A., H. Brismar, A.C. Eklöf and A. Aperia. Role of oxidative stress in advanced glycation end product-induced mesangial cell activation. Kidney Int. 61: 2006-2014, 2002.
23. Li, J., X. Qu and A.M. Schmidt. Sp1-binding elements in the promoter of RAGE are essential for amphoterin-mediated gene expression in cultured neuroblastoma cells. J. Biol. Chem. 273: 30870-30878, 1998.
24. Liu, D., H. Jiang and R.W. Grange. Genistein activates the 30,50-cyclic adenosine monophosphate signaling pathway in vascular endothelial cells and protects endothelial barrier function. Endocrinology 146: 1312-1320, 2005 .
25. Motoyoshi, S., Y. Yamamoto, S. Munesue, H. Igawa, A. Harashima, H. Saito, D. Han, T. Watanabe, H. Sato and H. Yamamoto. cAMP ameliorates inflammation by modulation of macrophage receptor for advanced g lycation end-products. Biochem. J. 463: 75-82, 2014.
26. Mueckler, M., C. Caruso, S.A. Baldwin, M. Panico, I. Blench, H.R. Morris, W.J. Allard, G.E. Lienhard and H.F. Lodish. Sequence and structure of a human glucose transporter. Science 229: 941-945, 1985.
27. Nevado, C., A.M. Valverde and M. Benito. Role of insulin receptor in the regulation of glucose uptake in neonatal hepatocytes. Endocrinology 147: 3709-3718, 2006.
28. Oróstica, M.L., J. Lopez, I. Rojas, J. Rocco, P. Díaz, P. Reuquén, H. Cardenas, A. Parada-Bustamante and P.A. Orihuela. Estradiol increases cAMP i n the oviductal secretory cells through a nongenomic mechanism. Reproduction 148: 285-294, 2014.
29. Ravnskjaer, K., M.F. Hogan, D. Lackey, L. Tora, S.Y. Dent, J. Olefsky and M. Montminy. Glucag on regulates gluconeogenesis through KAT2B-And WDR5-mediated epigenetic effects. J. Clin. Invest. 123: 4318-4328, 2013.
30. Singh, V.P., A. Bali, N. Singh and A.S. Jaggi. Advanced glycation end products and diabetic complications. Korean J. Physiol. Pharmacol. 18: 1-14, 2014.
31. Tan K.C.,S.W. Shiu,Y. Wong,X. Tam Serum advanced glycation end products (AGEs) are associated with insulin resistance. Diabetes. Metab. Res. Rev. 27 488-492 2011.
32. Thornalley, P.J. Dietary AGEs and ALEs and risk to human health by their interaction with the receptor for advanced glycation end products (RAGE)-An introduction. Mol. Nutr. Food Res. 51: 1107-1110, 2007.
33. Wu, P., P. He, S. Zhao, T. Huang, Y. Lu and K. Zhang. Effects of ursolic acid derivatives on Caco-2 cells and their alleviating role in streptozocin-induced type 2 diabetic rats. Molecules 19: 12559-12576, 2014.
34. Xu, Y., L. Feng, S. Wang, Q. Zhu, Z. Zheng, P. Xiang, B. He and D. Tang. Calycosin protects HUVECs from advanced glycation end products-induced macrophage in filtration. J. Ethnopharmacol. 137: 359-370, 2011.
35. Xu, Y., S. Wang, L. Feng, Q. Zhu, P. Xiang and B. He. Blockade of PKC-beta protects HUVEC from advanced glycation end products induced inflammation. Int. Immunopharmacol. 10: 1552-1559, 2010.
36. Xu, Y.H., J. Xiong, S.S. Wang, D. Tang, R.S. Wang and Q. Zhu. Calycosin entered HUVECs and ameliorated AGEs-promoted cell apoptosis via the Bcl-2 pathway. J. Nat. Med. 68: 163-172, 2014.
37. Yamatani, K., K. Saito, H. Ohnuma, Y. Ikezawa, T. Seino, Y. Manaka, M. Daimon, K. Takahashi and H. Sasaki. Increased epinephrine-induced cAMP response in severely diabetic BB/W rat liver. Endocr. J. 44: 725-732, 1997.
38. Yan, S.D., A.M. Schmidt, G.M. Anderso n, J. Zhang, J. Brett, Y.S. Zou, D. Pinsky and D. Stern. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J. Biol. Chem. 269: 9889-9897, 1 994.
39. Zhang, X., J. Xu, X. Cai, L. Ji, J. Li, B. Cao, J. Li, D. Hu, Y. Li, H. Wang, L. Xiong, R. Xiao and F. Gao. Acute insulin resistance mediated by advanced glycation end products in se verely burned rats. Crit. Care. Med. 42: e472-e480, 2014a .
40. Zhang, F., Y. Wei, Y. Zhou, D. Wang, L. Zhou, J. Zhang and X. Wu. Pharmacokinetics and hepatic uptake of gliquidone affected by Huangqi injection. Eur. J. Drug. Metab. Pharmacokinet. 39: 255-261, 2014 b.
41. Zhao, F.Q. and A.F. Keating. Functional properties and genomics of glucose transporters. Curr. Genomics. 8: 113-128, 2007.